Dastyafteh N

References (7)

Title : Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico study - Shokouhi_2025_Sci.Rep_15_655
Author(s) : Shokouhi Asl AS , Sayahi MH , Hashempur MH , Irajie C , Alaeddini AH , Ghafouri SN , Noori M , Dastyafteh N , Mottaghipisheh J , Asadi M , Larijani B , Mahdavi M , Iraji A
Ref : Sci Rep , 15 :655 , 2025
Abstract :
PubMedSearch : Shokouhi_2025_Sci.Rep_15_655
PubMedID: 39754023

Title : Rhodanine-pyridinium derivatives as a new category of cholinesterase inhibitors: Design, synthesis, in vitro and in silico enzymatic evaluations - Noori_2025_Int.J.Biol.Macromol__145731
Author(s) : Noori M , Karimian S , Dastyafteh N , Ghafouri SN , Mohammadi-Khanaposhtani M , Safapoor S , Ghomi MK , Rastegar H , Saeedi S , Larijani B , Mahdavi M , Aktas A , Taslimi P , Gulcin I
Ref : Int J Biol Macromol , :145731 , 2025
Abstract :
PubMedSearch : Noori_2025_Int.J.Biol.Macromol__145731
PubMedID: 40617434

Title : New benzimidazole-indole-amide derivatives as potent alpha-glucosidase and acetylcholinesterase inhibitors - Naimi_2025_Arch.Pharm.(Weinheim)_358_e2400354
Author(s) : Naimi N , Karimian S , Dastyafteh N , Noori M , Mohammadi-Khanaposhtani M , Dadgar A , Larijani B , Lotfi V , Celik I , Aktas A , Sadeghian N , Taslimi P , Mahdavi M
Ref : Arch Pharm (Weinheim) , 358 :e2400354 , 2025
Abstract :
PubMedSearch : Naimi_2025_Arch.Pharm.(Weinheim)_358_e2400354
PubMedID: 39721987

Title : New 1E,1'E-hydrazine-bis(phenoxy-1,2,3-triazol-acetamide) derivatives as potent inhibitors against acetylcholinesterase, butyrylcholinesterase, and alpha-glucosidase - Kermaninia_2025_RSC.Adv_15_29960
Author(s) : Kermaninia S , Mohammadi-Khanaposhtani M , Senol H , Khajeh Mohammadilar FS , Dastyafteh N , Moradkhani F , Saeedi S , Larijani B , Dadgar A , Aktas A , Sadeghian N , Taslimi P , Mahdavi M
Ref : RSC Adv , 15 :29960 , 2025
Abstract :
PubMedSearch : Kermaninia_2025_RSC.Adv_15_29960
PubMedID: 40860056

Title : Isoindolinedione-Benzamide Pyridinium Derivatives for Targeting Alzheimer's Disease - Noori_2024_ACS.Omega_9_48032
Author(s) : Noori M , Khalili Ghomi M , Dastyafteh N , Oliyaei N , Hamedifar H , Javanshir S , Tanideh N , Sattarinezhad E , Sattari F , Haghani M , Rahmani H , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : ACS Omega , 9 :48032 , 2024
Abstract :
PubMedSearch : Noori_2024_ACS.Omega_9_48032
PubMedID: 39676969

Title : Phenyl-quinoline derivatives as a lead structure of cholinesterase inhibitor endowed with potency to reduce the GSK-3beta level targeting Alzheimer's disease - Noori_2023_Int.J.Biol.Macromol__127392
Author(s) : Noori M , Dastyafteh N , Safapoor S , Ghomi MK , Tanideh R , Zomorian K , Hamedifar H , Dara M , Zare S , Irajie C , Javanshir S , Rastegar H , Panahi N , Larijani B , Mahdavi M , Hajimiri MH , Iraji A
Ref : Int J Biol Macromol , :127392 , 2023
Abstract :
PubMedSearch : Noori_2023_Int.J.Biol.Macromol__127392
PubMedID: 37827412

Title : New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and alpha-glucosidase enzymes - Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
Author(s) : Mohammadi-Khanaposhtani M , Nori M , Valizadeh Y , Javanshir S , Dastyafteh N , Moaazam A , Hosseini S , Larijani B , Adibi H , Biglar M , Hamedifar H , Mahdavi M , Kamci H , Karakus A , Taslimi P
Ref : Arch Pharm (Weinheim) , :e2100313 , 2022
Abstract :
PubMedSearch : Mohammadi-Khanaposhtani_2022_Arch.Pharm.(Weinheim)__e2100313
PubMedID: 35132681